Sort
15,842 grants matching “pancreatic cancer”
Targeting the RNA Exosome for Cancer Therapeutics
$479,616Mats Ljungman · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$479,612Eric T. Kool · Stanford University · R01 · FY2019 · CA
Overcoming stromal barriers to therapeutics in pancreas cancer
$479,510Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
A CELL-BASED APPROACH TO EARLY PANCREATIC CANCER DETECTION
$479,488Trustees Of The University Of Pennsylvania, The · · FY2015 · Department of Defense
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
$479,470Mark R. Kelley · Indiana University Indianapolis · R01 · FY2025 · CA
Drug Mechanism of Action-based targeting of tumor subpopulations
$479,435Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA
Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes
$479,389Nisa M Maruthur · Johns Hopkins University · R01 · FY2021 · DK
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$479,283Andre Elias Nel · University Of California Los Angeles · R01 · FY2024 · CA
Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression
$479,144Mark R. Kelley · Indiana University Indianapolis · R01 · FY2014 · CA
A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging
$478,857Esther H Chang · Synergene Therapeutics, Inc. · R41 · FY2006 · CA
Causes & Consequences of Acid pH in Tumors
$478,810Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Causes & Consequences of Acid pH in Tumors
$478,810Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
$478,754Julia Davydova · University Of Minnesota · R01 · FY2024 · CA
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
$478,728Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2018 · CA
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
$478,728Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2017 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$478,329Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$478,329Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Case Control Study of Pancreas Cancer in Shanghai, China
$478,305Harvey A Risch · Yale University · R01 · FY2010 · CA
The role of wild-type KRAS in the context of tumor profession and metastasis
$478,277Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2019 · CA
NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia
$478,114Denis C Guttridge · Medical University Of South Carolina · R01 · FY2022 · AR
Developing new therapeutic strategies for distinct Ras-driven cancers
$478,002Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2025 · CA
Metaplastic Tuft Cells in Pancreatic Cancer
$477,977Howard C Crawford · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research
$477,934Denis Wirtz · Johns Hopkins University · T32 · FY2023 · CA
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
$477,871Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
$477,871Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2019 · CA